

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.51932619 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 5.51932619 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.51932619 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.51932619 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.51932619 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.51932619 |
| 7 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.83483981 |
| 8 | macrophage activation involved in immune response (GO:0002281) | 4.20337784 |
| 9 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.07253525 |
| 10 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.05544876 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 4.04816762 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.02173331 |
| 13 | basic amino acid transport (GO:0015802) | 3.91698075 |
| 14 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.88685743 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.63366606 |
| 16 | NIK/NF-kappaB signaling (GO:0038061) | 3.58145262 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.57795323 |
| 18 | response to peptidoglycan (GO:0032494) | 3.56655126 |
| 19 | mannose metabolic process (GO:0006013) | 3.55754151 |
| 20 | positive regulation of interferon-alpha production (GO:0032727) | 3.50035580 |
| 21 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.49366172 |
| 22 | negative regulation of cell killing (GO:0031342) | 3.49366172 |
| 23 | phagosome maturation (GO:0090382) | 3.45587160 |
| 24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.42321524 |
| 25 | response to muramyl dipeptide (GO:0032495) | 3.38606909 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 3.36164371 |
| 27 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.35693291 |
| 28 | microglial cell activation (GO:0001774) | 3.33205106 |
| 29 | glycoside metabolic process (GO:0016137) | 3.31841580 |
| 30 | keratan sulfate catabolic process (GO:0042340) | 3.31766513 |
| 31 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.28812982 |
| 32 | regulation of interferon-alpha production (GO:0032647) | 3.26683289 |
| 33 | mature B cell differentiation involved in immune response (GO:0002313) | 3.24140367 |
| 34 | aldehyde catabolic process (GO:0046185) | 3.23938217 |
| 35 | regulation of cholesterol storage (GO:0010885) | 3.21243569 |
| 36 | barbed-end actin filament capping (GO:0051016) | 3.19123721 |
| 37 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.18382365 |
| 38 | response to host immune response (GO:0052572) | 3.18382365 |
| 39 | apoptotic cell clearance (GO:0043277) | 3.17528088 |
| 40 | low-density lipoprotein particle clearance (GO:0034383) | 3.14935940 |
| 41 | positive thymic T cell selection (GO:0045059) | 3.14792149 |
| 42 | respiratory burst (GO:0045730) | 3.14146471 |
| 43 | macroautophagy (GO:0016236) | 3.13764338 |
| 44 | folic acid transport (GO:0015884) | 3.11172679 |
| 45 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.08807809 |
| 46 | regulation of mast cell degranulation (GO:0043304) | 3.00542002 |
| 47 | regulation of gamma-delta T cell activation (GO:0046643) | 2.99686241 |
| 48 | germinal center formation (GO:0002467) | 2.98454293 |
| 49 | regulation of leukocyte degranulation (GO:0043300) | 2.94923361 |
| 50 | macrophage activation (GO:0042116) | 2.94710992 |
| 51 | negative regulation of interleukin-12 production (GO:0032695) | 2.94682277 |
| 52 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.92072900 |
| 53 | transferrin transport (GO:0033572) | 2.92032435 |
| 54 | Golgi transport vesicle coating (GO:0048200) | 2.89989636 |
| 55 | COPI coating of Golgi vesicle (GO:0048205) | 2.89989636 |
| 56 | amyloid precursor protein catabolic process (GO:0042987) | 2.88926491 |
| 57 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.88336849 |
| 58 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.88336849 |
| 59 | intracellular pH reduction (GO:0051452) | 2.88165325 |
| 60 | detection of bacterium (GO:0016045) | 2.87879121 |
| 61 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.87446387 |
| 62 | immunoglobulin mediated immune response (GO:0016064) | 2.86548197 |
| 63 | reactive oxygen species biosynthetic process (GO:1903409) | 2.86437097 |
| 64 | modulation by symbiont of host cellular process (GO:0044068) | 2.85531278 |
| 65 | response to thyroid hormone (GO:0097066) | 2.85215712 |
| 66 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.84583621 |
| 67 | amino sugar catabolic process (GO:0046348) | 2.84383397 |
| 68 | positive regulation of interferon-beta production (GO:0032728) | 2.82893351 |
| 69 | detection of other organism (GO:0098543) | 2.81555565 |
| 70 | glycolipid catabolic process (GO:0019377) | 2.80469952 |
| 71 | thymic T cell selection (GO:0045061) | 2.80298649 |
| 72 | plasma lipoprotein particle clearance (GO:0034381) | 2.80108980 |
| 73 | glycosphingolipid catabolic process (GO:0046479) | 2.80076937 |
| 74 | regulation of mononuclear cell migration (GO:0071675) | 2.79534276 |
| 75 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.78664304 |
| 76 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.77866320 |
| 77 | L-phenylalanine metabolic process (GO:0006558) | 2.77866320 |
| 78 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.77685480 |
| 79 | pH reduction (GO:0045851) | 2.77119759 |
| 80 | urate metabolic process (GO:0046415) | 2.76602104 |
| 81 | positive regulation of B cell differentiation (GO:0045579) | 2.75800400 |
| 82 | trivalent inorganic cation transport (GO:0072512) | 2.75612174 |
| 83 | ferric iron transport (GO:0015682) | 2.75612174 |
| 84 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.74513166 |
| 85 | cellular response to type I interferon (GO:0071357) | 2.74081941 |
| 86 | type I interferon signaling pathway (GO:0060337) | 2.74081941 |
| 87 | response to type I interferon (GO:0034340) | 2.73727942 |
| 88 | pinocytosis (GO:0006907) | 2.73549216 |
| 89 | negative regulation of lipid storage (GO:0010888) | 2.71703461 |
| 90 | protein localization to endosome (GO:0036010) | 2.71699391 |
| 91 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.71658950 |
| 92 | protein carboxylation (GO:0018214) | 2.71658950 |
| 93 | response to lipoprotein particle (GO:0055094) | 2.71503116 |
| 94 | cysteine metabolic process (GO:0006534) | 2.68843630 |
| 95 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.68588111 |
| 96 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.66092430 |
| 97 | response to host (GO:0075136) | 2.66092430 |
| 98 | response to host defenses (GO:0052200) | 2.66092430 |
| 99 | L-ascorbic acid metabolic process (GO:0019852) | 2.64803684 |
| 100 | positive regulation of antigen processing and presentation (GO:0002579) | 2.64713404 |
| 101 | modulation by virus of host process (GO:0019054) | 2.64436551 |
| 102 | myeloid dendritic cell differentiation (GO:0043011) | 2.62838627 |
| 103 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.61575261 |
| 104 | positive regulation of leukocyte degranulation (GO:0043302) | 2.61111523 |
| 105 | I-kappaB phosphorylation (GO:0007252) | 2.60918616 |
| 106 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.60493310 |
| 107 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.60174924 |
| 108 | L-phenylalanine catabolic process (GO:0006559) | 2.60174924 |
| 109 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.59857290 |
| 110 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.59730123 |
| 111 | regulation of antigen processing and presentation (GO:0002577) | 2.59185251 |
| 112 | regulation of superoxide anion generation (GO:0032928) | 2.58685672 |
| 113 | natural killer cell mediated immunity (GO:0002228) | 2.56890968 |
| 114 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.56890968 |
| 115 | positive regulation of bone remodeling (GO:0046852) | 2.56812597 |
| 116 | positive regulation of bone resorption (GO:0045780) | 2.56812597 |
| 117 | lipoprotein transport (GO:0042953) | 2.56410388 |
| 118 | myeloid cell activation involved in immune response (GO:0002275) | 2.56011349 |
| 119 | activation of MAPKKK activity (GO:0000185) | 2.55594046 |
| 120 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.54648454 |
| 121 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.52677969 |
| 122 | phospholipid homeostasis (GO:0055091) | 2.52275496 |
| 123 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.51740223 |
| 124 | wound healing, spreading of epidermal cells (GO:0035313) | 2.51399988 |
| 125 | sulfur amino acid catabolic process (GO:0000098) | 2.51330419 |
| 126 | T cell selection (GO:0045058) | 2.50834274 |
| 127 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.50692386 |
| 128 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.50390292 |
| 129 | glyoxylate metabolic process (GO:0046487) | 2.49966927 |
| 130 | response to protozoan (GO:0001562) | 2.49737873 |
| 131 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.48940238 |
| 132 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.48692083 |
| 133 | negative regulation of innate immune response (GO:0045824) | 2.47716773 |
| 134 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.47677590 |
| 135 | regulation of monocyte differentiation (GO:0045655) | 2.47666864 |
| 136 | folic acid metabolic process (GO:0046655) | 2.46805866 |
| 137 | homocysteine metabolic process (GO:0050667) | 2.46714207 |
| 138 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.46471140 |
| 139 | cofactor catabolic process (GO:0051187) | 2.45505337 |
| 140 | eosinophil chemotaxis (GO:0048245) | 2.45100206 |
| 141 | myeloid dendritic cell activation (GO:0001773) | 2.45067003 |
| 142 | detection of external biotic stimulus (GO:0098581) | 2.44973885 |
| 143 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.44344358 |
| 144 | defense response to protozoan (GO:0042832) | 2.44195027 |
| 145 | purine nucleotide salvage (GO:0032261) | 2.44060938 |
| 146 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.43566822 |
| 147 | regulation of integrin activation (GO:0033623) | 2.43323896 |
| 148 | modified amino acid transport (GO:0072337) | 2.42706528 |
| 149 | leukocyte aggregation (GO:0070486) | 2.42679985 |
| 150 | regulation of complement activation (GO:0030449) | 2.42543311 |
| 151 | ceramide catabolic process (GO:0046514) | 2.41269386 |
| 152 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.41047382 |
| 153 | regulation of necrotic cell death (GO:0010939) | 2.40299419 |
| 154 | regulation of defense response to virus by virus (GO:0050690) | 2.40198624 |
| 155 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.40032111 |
| 156 | glycosylceramide metabolic process (GO:0006677) | 2.39971776 |
| 157 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.39149859 |
| 158 | negative regulation of granulocyte differentiation (GO:0030853) | 2.38790633 |
| 159 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.38579640 |
| 160 | T cell migration (GO:0072678) | 2.38469064 |
| 161 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.38403910 |
| 162 | negative regulation of cell size (GO:0045792) | 2.38279649 |
| 163 | regulation of tumor necrosis factor production (GO:0032680) | 2.37951939 |
| 164 | granulocyte activation (GO:0036230) | 2.37166279 |
| 165 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.36550675 |
| 166 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.36306787 |
| 167 | oligosaccharide catabolic process (GO:0009313) | 2.35744307 |
| 168 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.35217022 |
| 169 | mature B cell differentiation (GO:0002335) | 2.35094857 |
| 170 | regulation of regulated secretory pathway (GO:1903305) | 2.34594241 |
| 171 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.33471883 |
| 172 | negative thymic T cell selection (GO:0045060) | 2.32418295 |
| 173 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.30893848 |
| 174 | tolerance induction (GO:0002507) | 2.30650718 |
| 175 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.30146864 |
| 176 | adhesion of symbiont to host (GO:0044406) | 2.29772718 |
| 177 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.29755583 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.85160918 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.03507307 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.96998304 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.27122619 |
| 5 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.12357171 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.98584120 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.93920829 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.89693596 |
| 9 | TFEB_21752829_ChIP-Seq_HELA_Human | 2.71655305 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.71016131 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.60304686 |
| 12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.54966968 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.48150498 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.41300316 |
| 15 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.36342969 |
| 16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.26629454 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.25001488 |
| 18 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.24289483 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.23078562 |
| 20 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.22493968 |
| 21 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.16880496 |
| 22 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.06179817 |
| 23 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.03134711 |
| 24 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.02506394 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.98832759 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.95845828 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 1.87325543 |
| 28 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.84928811 |
| 29 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.79736360 |
| 30 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.79282405 |
| 31 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.77825376 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.76616747 |
| 33 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.72280856 |
| 34 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.70727036 |
| 35 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.69420841 |
| 36 | UTX_26944678_Chip-Seq_JUKART_Human | 1.67466221 |
| 37 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.66193199 |
| 38 | MAF_26560356_Chip-Seq_TH2_Human | 1.65486829 |
| 39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.63621077 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.63029998 |
| 41 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62776999 |
| 42 | P68_20966046_ChIP-Seq_HELA_Human | 1.61627007 |
| 43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.60355313 |
| 44 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.59233887 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54987479 |
| 46 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.54311900 |
| 47 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.53259834 |
| 48 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.51799793 |
| 49 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.50791657 |
| 50 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.49313494 |
| 51 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.49228924 |
| 52 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.48316868 |
| 53 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.47332430 |
| 54 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.46137154 |
| 55 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.45049548 |
| 56 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.44522328 |
| 57 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.42578464 |
| 58 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.41747843 |
| 59 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.40661015 |
| 60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39682808 |
| 61 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.39113717 |
| 62 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.36336194 |
| 63 | KDM2B_26808549_Chip-Seq_K562_Human | 1.35904843 |
| 64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35715346 |
| 65 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.35107360 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.33622099 |
| 67 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.32946361 |
| 68 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32227419 |
| 69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.32072002 |
| 70 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31491895 |
| 71 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.29915159 |
| 72 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.28321895 |
| 73 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.27862122 |
| 74 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.27859947 |
| 75 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.26976883 |
| 76 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.25496054 |
| 77 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.25047788 |
| 78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24914799 |
| 79 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.23560435 |
| 80 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.22703398 |
| 81 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21433627 |
| 82 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21392852 |
| 83 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.20802033 |
| 84 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.19975814 |
| 85 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.19960261 |
| 86 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19416182 |
| 87 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.19391673 |
| 88 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19083004 |
| 89 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.18755877 |
| 90 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17639027 |
| 91 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.17056179 |
| 92 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.17056179 |
| 93 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.17056179 |
| 94 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.16761117 |
| 95 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16550334 |
| 96 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.16522935 |
| 97 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.16493186 |
| 98 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.15317992 |
| 99 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14733558 |
| 100 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.14713536 |
| 101 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.14619032 |
| 102 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.14588671 |
| 103 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.14259999 |
| 104 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.14070019 |
| 105 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13908156 |
| 106 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13867652 |
| 107 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.13206870 |
| 108 | SPI1_23127762_ChIP-Seq_K562_Human | 1.12318426 |
| 109 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.12235251 |
| 110 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11566198 |
| 111 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.10836498 |
| 112 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10620223 |
| 113 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10423674 |
| 114 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.10419711 |
| 115 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.10209979 |
| 116 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09799608 |
| 117 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.09632814 |
| 118 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.09294735 |
| 119 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07246600 |
| 120 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.06486243 |
| 121 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06478205 |
| 122 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.05908582 |
| 123 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05758785 |
| 124 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.04618703 |
| 125 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.04527407 |
| 126 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.04517937 |
| 127 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04513906 |
| 128 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03012069 |
| 129 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02408868 |
| 130 | MYB_26560356_Chip-Seq_TH1_Human | 1.02304186 |
| 131 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01160334 |
| 132 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.01156169 |
| 133 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.99137075 |
| 134 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.99051924 |
| 135 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.97275721 |
| 136 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.97128390 |
| 137 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.97092685 |
| 138 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.96562743 |
| 139 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.96212480 |
| 140 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.95258883 |
| 141 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.95051713 |
| 142 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.93916739 |
| 143 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.93519830 |
| 144 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.93326872 |
| 145 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93204861 |
| 146 | ATF3_27146783_Chip-Seq_COLON_Human | 0.92819689 |
| 147 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89796136 |
| 148 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89796136 |
| 149 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.89468320 |
| 150 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.88126249 |
| 151 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.86929503 |
| 152 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86682965 |
| 153 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.86483461 |
| 154 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86000469 |
| 155 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.85698731 |
| 156 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.85332949 |
| 157 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.84538619 |
| 158 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.81934727 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 6.16492131 |
| 2 | MP0003172_abnormal_lysosome_physiology | 4.48989349 |
| 3 | MP0009840_abnormal_foam_cell | 3.85105476 |
| 4 | MP0006082_CNS_inflammation | 2.95455312 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 2.72896754 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 2.69226010 |
| 7 | MP0003195_calcinosis | 2.67124935 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 2.59175640 |
| 9 | MP0000604_amyloidosis | 2.57249465 |
| 10 | MP0005360_urolithiasis | 2.49275838 |
| 11 | MP0003436_decreased_susceptibility_to | 2.30533677 |
| 12 | MP0003300_gastrointestinal_ulcer | 2.23878895 |
| 13 | MP0003183_abnormal_peptide_metabolism | 2.09282509 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.06339223 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.04202554 |
| 16 | MP0005257_abnormal_intraocular_pressure | 2.03761128 |
| 17 | MP0001835_abnormal_antigen_presentation | 2.03725320 |
| 18 | MP0005671_abnormal_response_to | 2.02329848 |
| 19 | MP0002419_abnormal_innate_immunity | 2.01280283 |
| 20 | MP0005332_abnormal_amino_acid | 1.95135342 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 1.88300856 |
| 22 | MP0005397_hematopoietic_system_phenotyp | 1.87520567 |
| 23 | MP0001545_abnormal_hematopoietic_system | 1.87520567 |
| 24 | MP0003763_abnormal_thymus_physiology | 1.85027559 |
| 25 | MP0003690_abnormal_glial_cell | 1.84186592 |
| 26 | MP0005083_abnormal_biliary_tract | 1.79188138 |
| 27 | MP0000569_abnormal_digit_pigmentation | 1.78646885 |
| 28 | MP0002420_abnormal_adaptive_immunity | 1.77994161 |
| 29 | MP0003186_abnormal_redox_activity | 1.75972150 |
| 30 | MP0001958_emphysema | 1.74134985 |
| 31 | MP0001853_heart_inflammation | 1.66772528 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.65111160 |
| 33 | MP0003303_peritoneal_inflammation | 1.63210284 |
| 34 | MP0009643_abnormal_urine_homeostasis | 1.60612909 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.57490661 |
| 36 | MP0005365_abnormal_bile_salt | 1.55461127 |
| 37 | MP0005000_abnormal_immune_tolerance | 1.53443185 |
| 38 | MP0003252_abnormal_bile_duct | 1.47559596 |
| 39 | MP0010307_abnormal_tumor_latency | 1.45326366 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.44803429 |
| 41 | MP0008469_abnormal_protein_level | 1.43145504 |
| 42 | MP0009785_altered_susceptibility_to | 1.41591371 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.40298635 |
| 44 | MP0008260_abnormal_autophagy | 1.40271665 |
| 45 | MP0001756_abnormal_urination | 1.39693346 |
| 46 | MP0002254_reproductive_system_inflammat | 1.38437211 |
| 47 | MP0000716_abnormal_immune_system | 1.37285473 |
| 48 | MP0003453_abnormal_keratinocyte_physiol | 1.34775348 |
| 49 | MP0002398_abnormal_bone_marrow | 1.34577214 |
| 50 | MP0005085_abnormal_gallbladder_physiolo | 1.32747862 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.32017247 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.31218150 |
| 53 | MP0010386_abnormal_urinary_bladder | 1.30288565 |
| 54 | MP0004947_skin_inflammation | 1.29512440 |
| 55 | MP0005025_abnormal_response_to | 1.29095775 |
| 56 | MP0001873_stomach_inflammation | 1.28996743 |
| 57 | MP0005464_abnormal_platelet_physiology | 1.27174547 |
| 58 | MP0001790_abnormal_immune_system | 1.26435668 |
| 59 | MP0005387_immune_system_phenotype | 1.26435668 |
| 60 | MP0008875_abnormal_xenobiotic_pharmacok | 1.26152729 |
| 61 | MP0000371_diluted_coat_color | 1.20732829 |
| 62 | MP0001849_ear_inflammation | 1.20519437 |
| 63 | MP0000609_abnormal_liver_physiology | 1.19526490 |
| 64 | MP0003075_altered_response_to | 1.19361155 |
| 65 | MP0002933_joint_inflammation | 1.19172857 |
| 66 | MP0005408_hypopigmentation | 1.18873757 |
| 67 | MP0000858_altered_metastatic_potential | 1.17688402 |
| 68 | MP0010329_abnormal_lipoprotein_level | 1.16957754 |
| 69 | MP0002136_abnormal_kidney_physiology | 1.16786120 |
| 70 | MP0002429_abnormal_blood_cell | 1.16495088 |
| 71 | MP0003329_amyloid_beta_deposits | 1.15980672 |
| 72 | MP0003279_aneurysm | 1.15976183 |
| 73 | MP0001845_abnormal_inflammatory_respons | 1.15238917 |
| 74 | MP0002452_abnormal_antigen_presenting | 1.14872249 |
| 75 | MP0004858_abnormal_nervous_system | 1.13413469 |
| 76 | MP0001851_eye_inflammation | 1.12998634 |
| 77 | MP0003448_altered_tumor_morphology | 1.12874113 |
| 78 | MP0005319_abnormal_enzyme/_coenzyme | 1.12174502 |
| 79 | MP0003566_abnormal_cell_adhesion | 1.11103552 |
| 80 | MP0002722_abnormal_immune_system | 1.10882720 |
| 81 | MP0000689_abnormal_spleen_morphology | 1.09835710 |
| 82 | MP0009764_decreased_sensitivity_to | 1.09227639 |
| 83 | MP0001542_abnormal_bone_strength | 1.08810798 |
| 84 | MP0003724_increased_susceptibility_to | 1.08478048 |
| 85 | MP0001666_abnormal_nutrient_absorption | 1.07514453 |
| 86 | MP0005174_abnormal_tail_pigmentation | 1.06054675 |
| 87 | MP0002295_abnormal_pulmonary_circulatio | 1.05810232 |
| 88 | MP0004185_abnormal_adipocyte_glucose | 1.03478234 |
| 89 | MP0005666_abnormal_adipose_tissue | 1.02685815 |
| 90 | MP0005310_abnormal_salivary_gland | 1.02439253 |
| 91 | MP0002723_abnormal_immune_serum | 1.02334003 |
| 92 | MP0002877_abnormal_melanocyte_morpholog | 1.00978941 |
| 93 | MP0004043_abnormal_pH_regulation | 0.99872993 |
| 94 | MP0002118_abnormal_lipid_homeostasis | 0.99534407 |
| 95 | MP0000685_abnormal_immune_system | 0.98013363 |
| 96 | MP0003091_abnormal_cell_migration | 0.97702446 |
| 97 | MP0002168_other_aberrant_phenotype | 0.97279458 |
| 98 | MP0004808_abnormal_hematopoietic_stem | 0.96327078 |
| 99 | MP0003866_abnormal_defecation | 0.95915821 |
| 100 | MP0005076_abnormal_cell_differentiation | 0.95327069 |
| 101 | MP0005165_increased_susceptibility_to | 0.93406137 |
| 102 | MP0003656_abnormal_erythrocyte_physiolo | 0.92813084 |
| 103 | MP0003634_abnormal_glial_cell | 0.92770803 |
| 104 | MP0005023_abnormal_wound_healing | 0.92483737 |
| 105 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.88938802 |
| 106 | MP0009278_abnormal_bone_marrow | 0.88856197 |
| 107 | MP0005164_abnormal_response_to | 0.87461749 |
| 108 | MP0000920_abnormal_myelination | 0.87331372 |
| 109 | MP0005670_abnormal_white_adipose | 0.87164454 |
| 110 | MP0000598_abnormal_liver_morphology | 0.87119431 |
| 111 | MP0002405_respiratory_system_inflammati | 0.86759091 |
| 112 | MP0000681_abnormal_thyroid_gland | 0.86425605 |
| 113 | MP0008874_decreased_physiological_sensi | 0.86294847 |
| 114 | MP0003828_pulmonary_edema | 0.86257779 |
| 115 | MP0005636_abnormal_mineral_homeostasis | 0.85641735 |
| 116 | MP0005166_decreased_susceptibility_to | 0.85617467 |
| 117 | MP0000703_abnormal_thymus_morphology | 0.84780524 |
| 118 | MP0001800_abnormal_humoral_immune | 0.84384775 |
| 119 | MP0002090_abnormal_vision | 0.83943882 |
| 120 | MP0000343_altered_response_to | 0.83522760 |
| 121 | MP0004381_abnormal_hair_follicle | 0.82324898 |
| 122 | MP0000358_abnormal_cell_content/ | 0.81683829 |
| 123 | MP0009333_abnormal_splenocyte_physiolog | 0.81093171 |
| 124 | MP0008004_abnormal_stomach_pH | 0.78858141 |
| 125 | MP0009763_increased_sensitivity_to | 0.78703380 |
| 126 | MP0003795_abnormal_bone_structure | 0.77713576 |
| 127 | MP0002396_abnormal_hematopoietic_system | 0.77168089 |
| 128 | MP0005451_abnormal_body_composition | 0.76981873 |
| 129 | MP0002693_abnormal_pancreas_physiology | 0.75718233 |
| 130 | MP0005171_absent_coat_pigmentation | 0.75373799 |
| 131 | MP0001819_abnormal_immune_cell | 0.75302053 |
| 132 | MP0005375_adipose_tissue_phenotype | 0.75255573 |
| 133 | MP0000490_abnormal_crypts_of | 0.73968088 |
| 134 | MP0001764_abnormal_homeostasis | 0.73765362 |
| 135 | MP0005390_skeleton_phenotype | 0.73753082 |
| 136 | MP0004510_myositis | 0.73228460 |
| 137 | MP0000015_abnormal_ear_pigmentation | 0.73211026 |
| 138 | MP0001663_abnormal_digestive_system | 0.72906582 |
| 139 | MP0000249_abnormal_blood_vessel | 0.71677715 |
| 140 | MP0001348_abnormal_lacrimal_gland | 0.68248344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vacuolated lymphocytes (HP:0001922) | 6.94910758 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 5.89660336 |
| 3 | Dysostosis multiplex (HP:0000943) | 5.80383795 |
| 4 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.35034682 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.26710714 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.26710714 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 5.26710714 |
| 8 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.90421260 |
| 9 | Mucopolysacchariduria (HP:0008155) | 4.90421260 |
| 10 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.75367163 |
| 11 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.75367163 |
| 12 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.75367163 |
| 13 | Abnormality of macrophages (HP:0004311) | 4.25221123 |
| 14 | Axonal loss (HP:0003447) | 4.09006821 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 3.99101341 |
| 16 | Recurrent abscess formation (HP:0002722) | 3.96733705 |
| 17 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.88876784 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.58925871 |
| 19 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.58579145 |
| 20 | Cervical subluxation (HP:0003308) | 3.28648835 |
| 21 | Eczematoid dermatitis (HP:0000976) | 3.11490080 |
| 22 | Vertebral compression fractures (HP:0002953) | 3.03695394 |
| 23 | Pathologic fracture (HP:0002756) | 2.88892088 |
| 24 | Global brain atrophy (HP:0002283) | 2.87659833 |
| 25 | Nuclear cataract (HP:0100018) | 2.79319217 |
| 26 | Purpura (HP:0000979) | 2.76115855 |
| 27 | Cellulitis (HP:0100658) | 2.72796303 |
| 28 | Xanthomatosis (HP:0000991) | 2.72306130 |
| 29 | Petechiae (HP:0000967) | 2.68693834 |
| 30 | Obstructive lung disease (HP:0006536) | 2.68482203 |
| 31 | Chronic obstructive pulmonary disease (HP:0006510) | 2.68482203 |
| 32 | Mediastinal lymphadenopathy (HP:0100721) | 2.65022400 |
| 33 | Myocardial infarction (HP:0001658) | 2.63924645 |
| 34 | Glomerulonephritis (HP:0000099) | 2.59262053 |
| 35 | Loss of speech (HP:0002371) | 2.58621825 |
| 36 | Myositis (HP:0100614) | 2.56848870 |
| 37 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.56365671 |
| 38 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.50355147 |
| 39 | Increased IgE level (HP:0003212) | 2.49626062 |
| 40 | Colitis (HP:0002583) | 2.47633986 |
| 41 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.42665004 |
| 42 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.40749427 |
| 43 | Upper motor neuron abnormality (HP:0002127) | 2.40707067 |
| 44 | Retinal atrophy (HP:0001105) | 2.36475616 |
| 45 | Neuronal loss in central nervous system (HP:0002529) | 2.36361116 |
| 46 | Beaking of vertebral bodies (HP:0004568) | 2.34738793 |
| 47 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.34306027 |
| 48 | Peripheral demyelination (HP:0011096) | 2.30042897 |
| 49 | Gingivitis (HP:0000230) | 2.29798090 |
| 50 | Interstitial pulmonary disease (HP:0006530) | 2.28316016 |
| 51 | Autoimmune thrombocytopenia (HP:0001973) | 2.25448838 |
| 52 | Recurrent fungal infections (HP:0002841) | 2.23769128 |
| 53 | Abnormality of purine metabolism (HP:0004352) | 2.23486142 |
| 54 | Gastrointestinal inflammation (HP:0004386) | 2.22742223 |
| 55 | Gastrointestinal stroma tumor (HP:0100723) | 2.22669811 |
| 56 | Cerebral inclusion bodies (HP:0100314) | 2.22595495 |
| 57 | Distal lower limb muscle weakness (HP:0009053) | 2.21817893 |
| 58 | Progressive neurologic deterioration (HP:0002344) | 2.20261730 |
| 59 | Complement deficiency (HP:0004431) | 2.19371388 |
| 60 | Agnosia (HP:0010524) | 2.18935304 |
| 61 | Hydroxyprolinuria (HP:0003080) | 2.16464197 |
| 62 | Abnormality of proline metabolism (HP:0010907) | 2.16464197 |
| 63 | Hypertensive crisis (HP:0100735) | 2.15960388 |
| 64 | Abnormality of complement system (HP:0005339) | 2.14526892 |
| 65 | Personality changes (HP:0000751) | 2.13119254 |
| 66 | Achilles tendon contracture (HP:0001771) | 2.12962828 |
| 67 | Abnormality of the nasal mucosa (HP:0000433) | 2.11341465 |
| 68 | Thoracic kyphosis (HP:0002942) | 2.11253340 |
| 69 | Premature rupture of membranes (HP:0001788) | 2.11162347 |
| 70 | Meningitis (HP:0001287) | 2.10376635 |
| 71 | Recurrent viral infections (HP:0004429) | 2.09789703 |
| 72 | Amyloidosis (HP:0011034) | 2.09203303 |
| 73 | Orchitis (HP:0100796) | 2.08541008 |
| 74 | Neurofibrillary tangles (HP:0002185) | 2.05917337 |
| 75 | Joint hemorrhage (HP:0005261) | 2.05337920 |
| 76 | Turricephaly (HP:0000262) | 2.04825534 |
| 77 | Sensorimotor neuropathy (HP:0007141) | 2.04581071 |
| 78 | Prolonged neonatal jaundice (HP:0006579) | 2.03974134 |
| 79 | Inflammation of the large intestine (HP:0002037) | 2.03200486 |
| 80 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.02321852 |
| 81 | Gout (HP:0001997) | 2.02309093 |
| 82 | Recurrent skin infections (HP:0001581) | 1.99622869 |
| 83 | Ovoid vertebral bodies (HP:0003300) | 1.98685824 |
| 84 | Conjunctival telangiectasia (HP:0000524) | 1.98122745 |
| 85 | Broad face (HP:0000283) | 1.97371029 |
| 86 | Disinhibition (HP:0000734) | 1.97222701 |
| 87 | Epistaxis (HP:0000421) | 1.97150053 |
| 88 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.96764612 |
| 89 | Hepatosplenomegaly (HP:0001433) | 1.96651018 |
| 90 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.96375874 |
| 91 | Ketoacidosis (HP:0001993) | 1.96177329 |
| 92 | Spontaneous hematomas (HP:0007420) | 1.95784089 |
| 93 | Hand muscle atrophy (HP:0009130) | 1.95775131 |
| 94 | Obstructive sleep apnea (HP:0002870) | 1.95419142 |
| 95 | Increased CSF protein (HP:0002922) | 1.95360283 |
| 96 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.93762554 |
| 97 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.93639368 |
| 98 | Osteolytic defects of the hand bones (HP:0009699) | 1.93639368 |
| 99 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.93009597 |
| 100 | Joint stiffness (HP:0001387) | 1.92125405 |
| 101 | Diminished motivation (HP:0000745) | 1.92006715 |
| 102 | Increased serum ferritin (HP:0003281) | 1.91444125 |
| 103 | Spinal muscular atrophy (HP:0007269) | 1.91237903 |
| 104 | Abnormality of nucleobase metabolism (HP:0010932) | 1.91223975 |
| 105 | Prolonged bleeding time (HP:0003010) | 1.91093141 |
| 106 | Emphysema (HP:0002097) | 1.90145584 |
| 107 | Abnormality of the Achilles tendon (HP:0005109) | 1.90010583 |
| 108 | Progressive visual loss (HP:0000529) | 1.89889370 |
| 109 | J-shaped sella turcica (HP:0002680) | 1.89781250 |
| 110 | Hypokinesia (HP:0002375) | 1.89765234 |
| 111 | Nausea (HP:0002018) | 1.88507492 |
| 112 | Thin bony cortex (HP:0002753) | 1.88490827 |
| 113 | Abnormality of the thoracic spine (HP:0100711) | 1.88307819 |
| 114 | Intrahepatic cholestasis (HP:0001406) | 1.88299251 |
| 115 | Poor head control (HP:0002421) | 1.88003736 |
| 116 | Agammaglobulinemia (HP:0004432) | 1.87322206 |
| 117 | Bone pain (HP:0002653) | 1.87066315 |
| 118 | Protuberant abdomen (HP:0001538) | 1.86761269 |
| 119 | Nephritis (HP:0000123) | 1.86697891 |
| 120 | Hyperglycinuria (HP:0003108) | 1.86149882 |
| 121 | Ketosis (HP:0001946) | 1.85949060 |
| 122 | Hyperacusis (HP:0010780) | 1.85709987 |
| 123 | Skin nodule (HP:0200036) | 1.84478733 |
| 124 | Hypertriglyceridemia (HP:0002155) | 1.84260752 |
| 125 | Restrictive lung disease (HP:0002091) | 1.83834390 |
| 126 | Neurodegeneration (HP:0002180) | 1.83701238 |
| 127 | Apathy (HP:0000741) | 1.83381792 |
| 128 | Cerebral aneurysm (HP:0004944) | 1.83375466 |
| 129 | Stomatitis (HP:0010280) | 1.83352739 |
| 130 | Ragged-red muscle fibers (HP:0003200) | 1.81695766 |
| 131 | Tetraparesis (HP:0002273) | 1.81512358 |
| 132 | Polygenic inheritance (HP:0010982) | 1.80374309 |
| 133 | Asymmetric septal hypertrophy (HP:0001670) | 1.80032507 |
| 134 | Peritonitis (HP:0002586) | 1.79546424 |
| 135 | Basal ganglia calcification (HP:0002135) | 1.79009868 |
| 136 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.78728498 |
| 137 | Elevated alkaline phosphatase (HP:0003155) | 1.78505401 |
| 138 | Cholecystitis (HP:0001082) | 1.78381244 |
| 139 | Abnormal gallbladder physiology (HP:0012438) | 1.78381244 |
| 140 | Hypophosphatemia (HP:0002148) | 1.77021243 |
| 141 | Hemorrhage of the eye (HP:0011885) | 1.76885150 |
| 142 | Polycythemia (HP:0001901) | 1.76852652 |
| 143 | Hypoplasia of the odontoid process (HP:0003311) | 1.76597000 |
| 144 | Fatigue (HP:0012378) | 1.76579112 |
| 145 | Vasculitis (HP:0002633) | 1.76439627 |
| 146 | Mutism (HP:0002300) | 1.76248890 |
| 147 | Pustule (HP:0200039) | 1.75821024 |
| 148 | Abnormality of iron homeostasis (HP:0011031) | 1.75675222 |
| 149 | Distal lower limb amyotrophy (HP:0008944) | 1.74575685 |
| 150 | Clumsiness (HP:0002312) | 1.74149907 |
| 151 | Supranuclear gaze palsy (HP:0000605) | 1.68593479 |
| 152 | Spondylolisthesis (HP:0003302) | 1.68276113 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.30279151 |
| 2 | IRAK3 | 4.13157688 |
| 3 | PRPF4B | 2.97319662 |
| 4 | MAP3K14 | 2.55080119 |
| 5 | SCYL2 | 2.53647005 |
| 6 | RIPK4 | 2.52167487 |
| 7 | TYK2 | 2.48155479 |
| 8 | BCKDK | 2.46914188 |
| 9 | TBK1 | 2.31165634 |
| 10 | NME2 | 2.20389964 |
| 11 | BLK | 2.11838272 |
| 12 | TRIB3 | 2.06427901 |
| 13 | KIT | 2.05347412 |
| 14 | ARAF | 1.88270106 |
| 15 | PBK | 1.87873737 |
| 16 | MAP3K13 | 1.87476231 |
| 17 | EPHA2 | 1.81035534 |
| 18 | SMG1 | 1.75345568 |
| 19 | TESK1 | 1.74945071 |
| 20 | IRAK4 | 1.71933798 |
| 21 | ABL2 | 1.68412237 |
| 22 | CAMKK2 | 1.61772906 |
| 23 | TAOK3 | 1.59989800 |
| 24 | TGFBR2 | 1.58701212 |
| 25 | MET | 1.56179405 |
| 26 | TNK2 | 1.55687719 |
| 27 | IKBKB | 1.55551300 |
| 28 | PIM2 | 1.54667786 |
| 29 | JAK1 | 1.44272216 |
| 30 | FGR | 1.43549233 |
| 31 | MST1R | 1.43360259 |
| 32 | NEK9 | 1.40361570 |
| 33 | DDR2 | 1.40329479 |
| 34 | MAP3K3 | 1.39744680 |
| 35 | TAOK1 | 1.37642678 |
| 36 | MOS | 1.36183102 |
| 37 | ICK | 1.31375657 |
| 38 | NTRK1 | 1.30686264 |
| 39 | PAK4 | 1.29490278 |
| 40 | JAK3 | 1.26663233 |
| 41 | ZAP70 | 1.24347783 |
| 42 | FES | 1.23506677 |
| 43 | MAP3K2 | 1.20418778 |
| 44 | MAP4K1 | 1.14958055 |
| 45 | EEF2K | 1.12114251 |
| 46 | EIF2AK3 | 1.11512581 |
| 47 | FLT3 | 1.09247798 |
| 48 | PRKD2 | 1.07621552 |
| 49 | WNK3 | 1.05895258 |
| 50 | MARK3 | 1.04637234 |
| 51 | BTK | 1.03642078 |
| 52 | BMX | 1.01148570 |
| 53 | CDC42BPA | 0.99853544 |
| 54 | CSF1R | 0.99491473 |
| 55 | MARK2 | 0.97704011 |
| 56 | JAK2 | 0.97013781 |
| 57 | LRRK2 | 0.96595031 |
| 58 | TTN | 0.92339933 |
| 59 | EPHB1 | 0.89894450 |
| 60 | SIK2 | 0.87953582 |
| 61 | PTK6 | 0.87410243 |
| 62 | TRPM7 | 0.87190077 |
| 63 | FGFR4 | 0.86173771 |
| 64 | CSK | 0.85820620 |
| 65 | MAPK12 | 0.85410512 |
| 66 | PDGFRA | 0.85242162 |
| 67 | LYN | 0.83423815 |
| 68 | HCK | 0.82929350 |
| 69 | MAP2K6 | 0.82014547 |
| 70 | HIPK2 | 0.79281453 |
| 71 | SIK3 | 0.78162492 |
| 72 | PIM1 | 0.77034501 |
| 73 | BRAF | 0.76776602 |
| 74 | MAPKAPK3 | 0.75851791 |
| 75 | MATK | 0.75631969 |
| 76 | AKT3 | 0.73465848 |
| 77 | GRK6 | 0.73201903 |
| 78 | CAMK1D | 0.73166298 |
| 79 | BUB1 | 0.72704468 |
| 80 | RPS6KA2 | 0.72589110 |
| 81 | PTK2 | 0.71920172 |
| 82 | PDK2 | 0.70726920 |
| 83 | IRAK2 | 0.70640423 |
| 84 | EGFR | 0.70175445 |
| 85 | PRKCD | 0.70162070 |
| 86 | RPS6KL1 | 0.70109989 |
| 87 | RPS6KC1 | 0.70109989 |
| 88 | PDK1 | 0.67056758 |
| 89 | GSK3A | 0.66250026 |
| 90 | SYK | 0.66220966 |
| 91 | MAPK11 | 0.63903572 |
| 92 | WNK4 | 0.63628799 |
| 93 | MST4 | 0.63166278 |
| 94 | IKBKE | 0.62061811 |
| 95 | ERBB4 | 0.60631560 |
| 96 | KDR | 0.60506425 |
| 97 | MAP3K8 | 0.60492300 |
| 98 | PDPK1 | 0.59512811 |
| 99 | TESK2 | 0.58939315 |
| 100 | RPS6KA4 | 0.58794939 |
| 101 | MAP3K6 | 0.57419051 |
| 102 | STK10 | 0.54266992 |
| 103 | ABL1 | 0.54235260 |
| 104 | MAP3K11 | 0.53620681 |
| 105 | MAPK4 | 0.53402237 |
| 106 | MAPK7 | 0.52056147 |
| 107 | PRKD3 | 0.51496562 |
| 108 | ITK | 0.50785247 |
| 109 | RPS6KA6 | 0.50725203 |
| 110 | GRK7 | 0.50699952 |
| 111 | LCK | 0.49659485 |
| 112 | GRK5 | 0.49386342 |
| 113 | CHUK | 0.49290704 |
| 114 | PKN2 | 0.46873684 |
| 115 | DAPK3 | 0.45852432 |
| 116 | INSRR | 0.45589779 |
| 117 | CDK12 | 0.45263731 |
| 118 | YES1 | 0.43766324 |
| 119 | CAMKK1 | 0.43299949 |
| 120 | MAP2K3 | 0.43250020 |
| 121 | RIPK1 | 0.43243711 |
| 122 | SIK1 | 0.42955833 |
| 123 | KSR2 | 0.42888177 |
| 124 | CDK4 | 0.42566606 |
| 125 | BMPR2 | 0.42476420 |
| 126 | MAP2K2 | 0.42038415 |
| 127 | PRKD1 | 0.41565665 |
| 128 | PAK1 | 0.41480713 |
| 129 | MAP3K7 | 0.41334576 |
| 130 | MAPKAPK2 | 0.41278672 |
| 131 | PIK3CG | 0.40622298 |
| 132 | MAPK15 | 0.40397284 |
| 133 | DAPK1 | 0.40046273 |
| 134 | IRAK1 | 0.38331721 |
| 135 | PRKCH | 0.37176211 |
| 136 | MTOR | 0.35111641 |
| 137 | MAP3K1 | 0.34637987 |
| 138 | TAOK2 | 0.32451271 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Lysosome_Homo sapiens_hsa04142 | 4.41984192 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.96365234 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.84816726 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.85116685 |
| 5 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.65496604 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.20853282 |
| 7 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.19097299 |
| 8 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.14390376 |
| 9 | Phagosome_Homo sapiens_hsa04145 | 2.07648005 |
| 10 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.07261515 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.00038809 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.92732444 |
| 13 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.90494883 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.87030354 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.86129213 |
| 16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.82783513 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.79726394 |
| 18 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.71161300 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.60063546 |
| 20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.59517075 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.56662814 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.55850254 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.53314780 |
| 24 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.49314157 |
| 25 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.49004962 |
| 26 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.48401747 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.45924303 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.43483805 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.41331983 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.37765275 |
| 31 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.34867791 |
| 32 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.32520816 |
| 33 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.32261356 |
| 34 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.32056240 |
| 35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.31640395 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.31075929 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.29760937 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.28681699 |
| 39 | Malaria_Homo sapiens_hsa05144 | 1.27473561 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.25218131 |
| 41 | Leishmaniasis_Homo sapiens_hsa05140 | 1.23650320 |
| 42 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.21080780 |
| 43 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.21071395 |
| 44 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.19195527 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 1.17953219 |
| 46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.16741809 |
| 47 | Histidine metabolism_Homo sapiens_hsa00340 | 1.14843108 |
| 48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.14522554 |
| 49 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.13251814 |
| 50 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.09861026 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.09737745 |
| 52 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.09637778 |
| 53 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.08839384 |
| 54 | Proteasome_Homo sapiens_hsa03050 | 1.08767426 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.08169713 |
| 56 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.08085868 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.06868943 |
| 58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.06175996 |
| 59 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.05481235 |
| 60 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.04397042 |
| 61 | Pertussis_Homo sapiens_hsa05133 | 1.03721773 |
| 62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.03714411 |
| 63 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.02574888 |
| 64 | Shigellosis_Homo sapiens_hsa05131 | 1.02097351 |
| 65 | Prion diseases_Homo sapiens_hsa05020 | 1.01352778 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 1.00783271 |
| 67 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.99155869 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.98764109 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97997858 |
| 70 | Measles_Homo sapiens_hsa05162 | 0.97056547 |
| 71 | Bladder cancer_Homo sapiens_hsa05219 | 0.96402402 |
| 72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.94648696 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.94360207 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94070808 |
| 75 | Hepatitis B_Homo sapiens_hsa05161 | 0.93346481 |
| 76 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.92007923 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.92003284 |
| 78 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.91161527 |
| 79 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.90814535 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90306243 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89536899 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.87819752 |
| 83 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.86373171 |
| 84 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85745087 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84713132 |
| 86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84348417 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.82780537 |
| 88 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.82387291 |
| 89 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.80881419 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.79832291 |
| 91 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.79362669 |
| 92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78021937 |
| 93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77049571 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.76933222 |
| 95 | Platelet activation_Homo sapiens_hsa04611 | 0.75076903 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74730200 |
| 97 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74136583 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.73729540 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73337767 |
| 100 | Apoptosis_Homo sapiens_hsa04210 | 0.73203496 |
| 101 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.72203720 |
| 102 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72046685 |
| 103 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.70192079 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70083559 |
| 105 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.69078896 |
| 106 | Carbon metabolism_Homo sapiens_hsa01200 | 0.68915766 |
| 107 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.67605358 |
| 108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67113815 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66880983 |
| 110 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.66804103 |
| 111 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66331977 |
| 112 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.66269856 |
| 113 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.65832809 |
| 114 | Protein export_Homo sapiens_hsa03060 | 0.65646133 |
| 115 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.65531140 |
| 116 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64931696 |
| 117 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63683047 |
| 118 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.63544860 |
| 119 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.63436668 |
| 120 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63002443 |
| 121 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.62828767 |
| 122 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62516179 |
| 123 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61870168 |
| 124 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.61524917 |
| 125 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.59980306 |
| 126 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57878144 |
| 127 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.56975599 |
| 128 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.54294118 |
| 129 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54275708 |
| 130 | ABC transporters_Homo sapiens_hsa02010 | 0.54168348 |
| 131 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.53267960 |
| 132 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.52756120 |
| 133 | Insulin resistance_Homo sapiens_hsa04931 | 0.49331259 |
| 134 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.48265856 |
| 135 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.47560356 |
| 136 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.47125781 |
| 137 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.46511619 |
| 138 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46487886 |
| 139 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46260450 |
| 140 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46139990 |
| 141 | Bile secretion_Homo sapiens_hsa04976 | 0.45915467 |
| 142 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.45825318 |
| 143 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45287574 |
| 144 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45165953 |
| 145 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44993973 |
| 146 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44552223 |
| 147 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.44062037 |
| 148 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.43616833 |
| 149 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.43543882 |
| 150 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.42323645 |
| 151 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41950276 |
| 152 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.41765199 |
| 153 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41665988 |
| 154 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41558846 |
| 155 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.41041694 |
| 156 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.40624980 |
| 157 | Influenza A_Homo sapiens_hsa05164 | 0.40017466 |
| 158 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.39804565 |
| 159 | Amoebiasis_Homo sapiens_hsa05146 | 0.39330299 |
| 160 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38905244 |
| 161 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.37045684 |

